Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: Validation of two breast cancer nomograms

Clinical Breast Cancer

Volumn 10, Issue 6, 2010, Pages 445-451

  D'Eredita, Giovanni ^a   Troilo, Vito Leopoldo ^a   Giardina, Carmela ^a   Napoli, Anna ^a   Rubini, Giuseppe ^a   Fischetti, Fernando ^a   Berardi, Tommaso ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Axillary lymph node dissection; Macrometastasis; MSKCC nonogram; Tenon score

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER PATIENT; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEMORIAL SLOAN KETTERING CANCER CENTER NOMOGRAM; MICROMETASTASIS; NOMOGRAM; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENTINEL LYMPH NODE METASTASIS; TENON SCORE SYSTEM; VALIDATION STUDY; AXILLA; BREAST TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SENTINEL LYMPH NODE BIOPSY;

EID: 79952277520     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.3816/CBC.2010.n.058     Document Type: Article

References (48)

1. Giuliano AE, Haigh PI, Brennan MD, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18: 2553-9. (Pubitemid 30432521)
2. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-7. (Pubitemid 27270119)
3. Bolster MJ, Peer PG, Bult P, et al. Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol 2007; 14: 181-9. (Pubitemid 44954287)
4. Zavagno G, De Salvo GL, Bozza F, et al. Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer. Breast Cancer Res Treat 2004; 86: 171-9. (Pubitemid 38988020)
5. Nos C, Harding C, Freneaux P, et al. Predicting of tumour in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 2003; 90: 1354-60. (Pubitemid 37421669)
6. Cady B. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer. J Surg Oncol 1997; 66: 7-10. (Pubitemid 27381472)
7. Changsri C, Prakash S, Sandweiss L, et al. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Breast J 2004; 10: 392-7. (Pubitemid 39281310)
8. Cserni G. Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla. Eur J Surg Oncol 2001; 27: 532-8. (Pubitemid 32842722)
9. Viale G, Maiorano E, Pruneri G, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005; 241: 319-25.
10. Wada N, Imoto S, Yamauchi C, et al. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur J Surg Oncol 2006; 32: 29-33. (Pubitemid 43103984)
11. Farshid G, Pradhan M, Kollias J, et al. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. Breast 2004; 13: 494-501. (Pubitemid 39618822)
12. Tan YY, Fan YG, Lu Y, et al. Ratio of positive to total number of sentinel nodes predicts non sentinel node status in breast cancer patients. Breast J 2005; 11: 248-53. (Pubitemid 41026038)
13. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with non-sentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89: 574-81. (Pubitemid 30640103)
14. Wong SL, Edwards MJ, Chao C, et al. Predicting the status of the non-sentinel axillary nodes. Arch Surg 2001; 136: 563-8. (Pubitemid 32417547)
15. Guenther JM, Hansen NM, De Fronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive nodes. Arch Surg 2003; 138: 52-6. (Pubitemid 36055648)
16. Schrenk P, Konstantiniuk P, Wolfl S, et al. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 2005; 92: 707-13. (Pubitemid 40863189)
17. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003; 10: 1140-51. (Pubitemid 40486808)
18. Barranger E, Coutant C, Flahault A, et al. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 2005; 91: 113-9. (Pubitemid 40684923)
19. Pal A, Provenzano E, Duffy SW, et al. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 2008; 95: 302-9.
20. Kohrt HE, Olshen RA, Bermas HR, et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008; 8: 66.
21. D'Eredita G, Ferrarese F, Cecere V, et al. Subareolar injection may be more accurate than other techniques for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 2003; 10: 942-7. (Pubitemid 40486861)
22. D'Eredita G, Giardina C, Guerrieri AM, et al. A further validation of subareolar injection technique for sentinel lymph node biopsy. Ann Surg Oncol 2006; 13: 701-7.
23. D'Eredita G, Troilo VL, Giardina C, et al. L'iniezione subareolare per la biopsia del linfonodo sentinella nei tumori multipli della mammella. G Chir 2006; 27: 436-41.
24. Kern KA. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 1999; 189: 539-45.
25. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary lymph nodes for patients with breast carcinoma. Cancer 2001; 92: 1378-84. (Pubitemid 32947820)
26. Coutant C, Rouzier R, Fondrinier E, et al. Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study. Breast Cancer Res Treat 2009; 113: 537-43.
27. Hanley JA. McNeil BJ. A method of comparing the areas under receiving operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43. (Pubitemid 13033817)
28. Alran S, De Rycke Y, Fourchotte V, et al. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 2007; 14: 2195-201. (Pubitemid 47174905)
29. Kocsis L, Svebis M, Boross G, et al. Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 2004; 70: 1019-24.
30. Soni NK, Carmalt HL, Gillett DJ, et al. Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 2005; 31: 958-64. (Pubitemid 41671108)
31. Smidt ML, Kuster DM, van der Wilt GJ, et al. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of non-sentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 2005; 12: 1066-72. (Pubitemid 41660683)
32. Degnim AC, Reynolds C, Pantvaidya G, et al. Non-sentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005; 190: 543-50. (Pubitemid 41306072)
33. Lambert LA, Ayers GD, Hwang RF, et al. Validation of a breast cancer nomogram for predicting non-sentinel lymph node metastasis after a positive sentinel node biopsy. Ann Surg Oncol 2006; 13: 310-20. (Pubitemid 43255913)
34. Cripe MH, Beran LC, Liang WC, et al. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram. Am J Surg 2006; 192: 484-7. (Pubitemid 44344193)
35. Dauphine CE, Haukoos JS, Vargas MP, et al. Evaluation of three scoring systems predicting non sentinel node metastasis in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2007; 14: 1014-9.
36. Ponzone R, Maggiorotto F, Mariani L, et al. Comparison of two models for the prediction of non-sentinel node metastasis in breast cancer. Am J Surg 2007; 193: 686-92. (Pubitemid 46745283)
37. Bevilacqua JL, Kattan MW, Fey JV, et al. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol 2007; 25: 3670-9. (Pubitemid 47372606)
38. van la Parra RF, Ernst MF, Bevilacqua JL, et al. Validation of a nomogram to predict the risk of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Ann Surg Oncol 2009; 16: 1128-35.
39. Klar M, Jochmann A, Foeldi M, et al. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 2008; 112: 523-31.
40. Gur AS, Unal B, Johnson R, et al. Predictive probability of four different breast cancer nomograms for non-sentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 2009; 208: 229-35.
41. Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of non-sentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003; 10: 248-54. (Pubitemid 40486957)
42. Coutant C, Olivier C, Lambaudie E, et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 2009; 27: 2800-8.
43. Goyal A, Newcombe RG, Chhabra A, et al. Factors affecting failed localization and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res Treat 2006; 99: 203-8. (Pubitemid 44268268)
44. Martin RC, Chagpar A, Scoggins CR, et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 2005; 241: 1005-12.
45. Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001; 192: 684-9.
46. Reed J, Rosman M, Verbanac KM, et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/ Ann Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg 2009; 208: 333-40.
47. Calhoun KE, Hansen NM, TurnerRR, et al. Non sentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 2005; 190: 588-91. (Pubitemid 41306082)
48. van Rijk MC, Peterse JL, Nieweg OE, et al. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or sub micrometastases in sentinel lymph nodes. Cancer 2006; 107: 467-71. (Pubitemid 44107205)